Innohep Lawsuit News and Information
Innohep Lawsuits
Side effects of Innohep, a low molecular weight heparin, have been linked to an increased risk of death when used to treat deep vein thrombosis (DVT) or pulmonary embolism among patients with impaired renal function who are 70 years old or older.
All Articles Tagged With: "Innohep"
Innohep Death Risk for Elderly Leads to New Warning
Celgene Corp. sent a letter last week to healthcare providers warning that their blood thinner Innohep may increase the risk of death in elderly patients with kidney problems, recommending that alternative treatments be considered for these patients.
FDA: Innohep Side Effects Could Increase Death Risk for Patients Over 70
The FDA has issued an early communication about an on-going safety review into potential side effects of Innohep, a low-molecular weight heparin. The agency has asked the drug maker to revise the warning label to indicate the Innohep death risk for elderly patients with renal insufficiency could extend to those 70 and older.
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
